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22–46) at the same period, his calcaemia was normal
at 2.36mmol/l and his phosphataemia was elevated at
1.89mmol/l.
Concerning the post transplantation period, the time lag
between renal transplantation and the occurrence of
hypercalcaemia was extremely short, since hypercalcaemia
appeared only 9 days after renal transplantation. He
developed concomitantly marked hypophosphatemia with
value reaching 0.41mmol/l. While receiving the calcimimetic,
his estimated calcium intake was in the range of 500mg of
calcium per day since he had been advised to stop all dairy
products and to drink water with low calcium content. He
neither received oral calcium nor vitamin D supplement,
nor prescription of thiazide diuretic. The imunossupressive
regimen associated corticosteroids, intravenous immuno-
globulins, cyclosporine and mycophenolate mofetil during
the ﬁrst ten days post transplantation, then cyclosporine and
mycophenolate mofetil alone. Drug-drug interaction between
calcimimetic and the immunosuppressive agent is theoreti-
cally possible, since cinacalcet is primarily metabolized in the
liver by the cytochrome P450 isoforms (CYP), CYP3A4 and
CYP1A2 and since cyclosporine is also metabolized by
CYP3A4 [4]. Nevertheless cinacalcet is not an inhibitor nor
an inductor of CYP3A4. Thus a risk of drug-drug interaction
between cinacalcet and cyclosporine is weak and has not been
reported in clinical practice. Moreover no variation of
cyclosporine level, monitored by measure of a single sample
two hours post absorption cyclosporine (C2), has been noted
concomitantly to the introduction or the increasing doses
of cinacalcet.
As mentioned by Dr Drueke, Peacok and co-workers
showed that cinacalcet in a twice daily dose is more efﬁcient
in decreasing serum PTH concentration than once daily but
had no effect on serum calcium concentration in patients
chronically treated by cinacalcet [5]. In our case, cinacalcet
administration was scheduled once daily at the range of
30mg, 60mg and 90mg then twice daily at the range of
120mg per day with 60mg in the morning and 60mg in the
evening.
Surgical exploration revealed four parathyroid glands. The
weight of the right and left superior glands was respectively 84
and 133mg and the weight of the right and left inferior glands
respectively 543mg and 100mg. Surgical procedure was
subtotal parathyroidectomy. Histologic data revealed four
hyperplasic glands without adenoma or nodular aspect.
Serum calcium level and PTH rapidly recovered normal
range in the post operative period. After a transient
hypocalcaemia at 2,07mmol/l, calcaemia and phosphataemia
were perfectly normalized 6 days later. Two months
after parathyroidectomy, the PTH level was at 78pg/ml
with normal ionized calcium at 1.27mmol/l (normal range,
1.14–1.31), normal phosphataemia at 1.27mmol/l. Bone
remodelling markers such as osteocalcin were in the normal
range as 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D
serum circulating level. There was no alteration of renal
function.
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Renal vein thrombosis after renal
transplantation – early diagnosis by
duplex sonography prevented fatal outcome
Sir,
Complete renal vein thrombosis (RVT) after renal trans-
plantation has an incidence of 0.55 to 3.4% [1–4] and
accounts for up to one-third of early allograft losses [1,2].
In a large series, 73% were detected with a median delay
of 8 days [2] suggesting that RVT develops gradually,
presumably beginning as partial vein thrombosis. There
may thus be a narrow but important window for early
diagnosis of partial RVT, which would allow for timely
intervention.
We report on a patient who had delayed graft function
after cadaveric renal transplant. Duplex sonography showed
very high peak velocity in the renal vein (260 cm/s) just prior
to the anastomosis to the iliac vein suggesting a high grade
stenosis. Intrarenal resistive index (RI) was normal (0.59)
(Figure 1A). During the next 3 days repeated duplex
showed a progressive increase in RI up to 0.89 (Figure 1B)
and the appearance of a multiphasic ﬂow signal in the
hilar arteries (Figure 1C). Because of the high suspicion for
a clinically relevant renal vein stenosis, the patient was taken
to the operating room. The allograft was swollen and
during palpation the enlarged and ﬁrm renal vein softened
suggesting that some thrombotic material had been released.
Intraoperative duplex demonstrated a residual intraluminal
thrombus and a normalization of venous peak velocity.
The arterial ﬂow pattern had returned to a monophasic signal
with an RI of 0.60 (Figure 1D). Renal vein stenosis had
most likely been due to the renal vein being stretched and
ﬂattened at the point where it crossed the prominent external
iliac artery. This had resulted in a low ﬂow situation with
subsequent thrombus formation. In order to avoid a similar
compression of the renal vein, the allograft was repositioned
under duplex sonographic guidance. Immediately after the
operation, diuresis increased and serum creatinine fell to
94 mmol/l within 5 days.
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While complete (i.e. complete RVT) or incomplete
(i.e. venous stenosis) venous outﬂow obstruction is usually
not difﬁcult to diagnose by duplex sonography, the clinical
relevance of the latter is not clear. Some investigators have
reported that renal vein stenosis can cause major clinical
problems [5,6]. However, in our experience many patients
with a high grade venous stenosis have good allograft
function. In our patient, it was only the progressive increase
in RI and a change from a monophasic to a multiphasic
arterial ﬂow signal that suggested relevant venous obstruction
and allowed for timely intervention preventing likely loss of
the allograft due to complete RVT. It appears thus that
changes in the arterial ﬂow signal and RI are crucial to
distinguish relevant renal vein stenosis from increased venous
peak velocity without clinical signiﬁcance. Repeated duplex
sonography may therefore be a valuable tool to monitor
patients at risk for RVT in the ﬁrst 2 weeks post-transplant,
particularly in the presence of delayed graft function.
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First evidence of fatal hantavirus nephropathy in India,
mimicking leptospirosis
Sir,
In a recent Indian serosurvey [1], it was announced that ‘no
reports of hantavirus infections in humans from India existed
[before 2005]’. We wish to point out that serological and
clinical evidence of hantavirus infection in India was already
well documented before 2005.
From 1998 on, we screened leptospirosis-suspected cases in
India for the only known cosmopolitan hantavirus serotype,
Seoul virus (SEOV). Wild rats are the reservoir of SEOV
and these commensal rodents have a documented presence
worldwide [2], including India. SEOV can cause thrombo-
cytopenia with concomitant kidney and liver involvement,
thus, mimicking leptospirosis [2]. In addition to murine
SEOV, we have a policy to use also an arvicoline screening
antigen, i.e. from Puumala virus (PUUV). PUUV is spread in
Europe and Russia by bank voles, causing a milder form of
nephropathy with thrombocytopenia, called ‘nephropathia
epidemica’ (NE). This simple dual approach of screening
leptospirosis-suspected sera enabled us to document in 1992
the ﬁrst serologically conﬁrmed hantavirus cases in the
New World (Recife, Brazil) [3], as well as in the
Netherlands [4] and in Northern Ireland [5].
In short, we detected hantavirus-speciﬁc immunoglobulin
(Ig) G and IgM antibodies by strip immunoblot assay (SIA)
layered with SEOV and PUUV recombinant nucleoproteins
(rNP) (courtesy of Brian Hjelle, University of New Mexico)
and by PUUV rNP enzyme-linked immunosorbent assay
(ELISA). All studied sera had to be seronegative for
leptospirosis in micro-aggluntination test (MAT) testing in
India, and negative again in our hands with a speciﬁc and
probably more sensitive Patoc–IgG and –IgM ELISA test.
Dengue infection was likewise serologically excluded by
immunochromatography.
In a ﬁrst 1998–1999 serosurvey, we found evidence of
SEOV-like and/or PUVV-like antibodies [6]. Up to 2000,
however, no clinically documented hantavirus cases had been
reported from India. Therefore, we started a prospective
study in the Chennai and Cochin area in southern India,
investigating leptospirosis-suspected but MAT- and Patoc
ELISA-negative cases. We detected 7/60 (12%) positives for
SEOV in IgG SIA, i.e. showing a higher band intensity for
SEOV than for PUUV, and 3/60 (5%) PUUV-positives. All
IgG SIA-positives, except one SEOVþ serum, were also IgM
SIA-positive, thus, conﬁrming for the ﬁrst time recent
hantavirus infections in at least nine Indian cases [7]. Two
cases were fatal: one in Chennai and one in Cochin. Both
patients had developed dialysis-requiring acute renal failure
with severe hypoxia.
Fig. 1. Development of the arterial ﬂow signal and intrarenal
resistive index (RI). (A) Results obtained immediately after
transplantation showing a monophasic ﬂow signal with an RI of
0.59. (B) Results obtained on postoperative day two still showing
a monophasic ﬂow signal with an increased RI of 0.85. (C) Results
obtained on postoperative day four illustrating the appearance of
a multiphasic ﬂow signal with an RI of 0.89. (D) Results obtained
after successful operative revision again demonstrating a mono-
phasic ﬂow signal with an RI of 0.60.
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